Palos Community Hospital’s Cancer Program recognized with Outstanding Achievement Award
Palos Community Hospital’s cancer program was recently presented with the 2014 Outstanding Achievement Award from the Commission on Cancer (CoC) of the American College of Surgeons.
Palos is one of a select group of five hospitals in Illinois and only 75 hospitals in the United States with accredited cancer programs to receive the prestigious award.
The purpose of the award is to raise the bar on quality cancer care, with the ultimate goal of increasing awareness about quality care choices among cancer patients and their loved ones. In addition, the award is intended to:
- Recognize cancer programs that achieve excellence in providing quality care to cancer patients.
- Motivate other cancer programs to work toward improving their level of care.
- Encourage honorees to serve as quality-care resources to other cancer programs.
The recognition is based on an on-site survey resulting in Palos receiving Accreditation with Commendation from the Commission for its cancer program. That designation demonstrates that Palos meets the highest national standards for state-of-the-art cancer prevention, early diagnosis, pretreatment evaluation, staging, optimal treatment, rehabilitation, surveillance for recurrent disease, support services and end-of-life care.
“These 75 cancer programs currently represent the best of the best – so to speak – when it comes to cancer care,” explains Daniel P. McKellar, M.D., FACS, chairman of the CoC. “Each of these facilities is not just meeting nationally recognized standards for the delivery of quality cancer care, they are exceeding them.”
Founded in 1922 by the American College of Surgeons, the Commission on Cancer is a consortium of professional organizations dedicated to improving survival and quality of life for cancer patients through standard-setting, prevention, research, education and the monitoring of comprehensive quality care.
Palos Community Hospital’s cancer program was honored with the 2014 Outstanding Achievement Award from the Commission on Cancer.